Table 1.
Clinicopathological characteristics of the study patients
| Variable | Value |
|---|---|
| Age (yr) | 59.0±10.9 |
| Sex | |
| Male | 888 (64.2) |
| Female | 496 (35.8) |
| Pathologic stage | |
| yp stage 0-2 | 911 (65.8) |
| yp stage 3 | 473 (34.2) |
| Preoperative chemoradiotherapy | |
| Yes | 536 (38.7) |
| No | 848 (61.3) |
| Surgical procedure | |
| Abdominoperineal resection | 157 (11.3) |
| Hartmann procedure | 7 (0.5) |
| Sphincter preserving resection | 1,220 (88.2) |
| Adjuvant chemotherapy | |
| Yes | 731 (52.8) |
| No | 653 (47.1) |
| Sarcopenia | |
| Yes | 944 (68.2) |
| No | 440 (31.8) |
| Sarcopenic obesity | |
| Yes | 307 (22.2) |
| No | 1,077 (77.8) |
| Visceral obesity | |
| Yes | 670 (48.4) |
| No | 714 (51.6) |
| Body mass index (kg/m2) | 23.9±4.4 |
| < 18.5 | 57 (4.1) |
| 18.5-23 | 494 (35.7) |
| 23-25 | 375 (27.1) |
| 25-30 | 416 (30.1) |
| > 30 | 42 (3.0) |
| Neutrophil-lymphocyte ratio | 2.33±1.68 |
| < 3 | 1,099 (79.8) |
| ≥ 3 | 278 (20.2) |
Values are presented as mean±standard deviation or number (%).